Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) crossed below its 200-day moving average during trading on Friday . Organicell Regenerative Medicine shares last traded at $1.45, with a volume of 296 shares changing hands. Organicell Regenerative Medicine Stock PerformanceThe business has a 50 day moving average of $1.74 and a 200-day moving average of $2.02. Get Organicell Regenerative Medicine alerts:Organicell Regenerative Medicine Company Profile(Get Free Report)Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. See AlsoReceive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.